Results 81 to 90 of about 334,286 (214)

Role of PASCAL and optical coherence tomography angiograpgy in the treatment of diffuse unilateral subacute neuroretinitis caused by large live motile worm

open access: yesIndian Journal of Ophthalmology, 2019
A 46-year-old male presented with best corrected visual acuity (BCVA) of 20/125 in his right eye. Fundus showed disc edema, multiple yellow outer retinal crops, macular edema and a live motile worm in the subretinal space. Diagnosis of diffuse unilateral
Navya Cherukuri   +4 more
doaj   +1 more source

Assessing the presence of Wuchereria bancrofti in vector and human populations from urban communities in Conakry, Guinea [PDF]

open access: yes, 2015
The Global Programme to Eliminate Lymphatic Filariasis was launched in 2000 with the goal of interrupting transmission of lymphatic filariasis (LF) through multiple rounds of mass drug administration (MDA).
Boakye, Daniel A.   +11 more
core   +4 more sources

Long-term persistence of cellular hyporesponsiveness to filarial antigens after clearance microfilaraemia [PDF]

open access: yes, 1999
The persistence of parasite-specific cellular hyporesponsiveness after clearance of blood microfilariae (mf) was studied in 18 individuals who had been treated with a single dose of ivermectin, diethylcarbamazine, or a combination 2-3 years previously ...
Gopinath, R   +7 more
core  

Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control [PDF]

open access: yes, 2011
Background The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was established by the World Health Organisation (WHO) in 2000 with the goal of eliminating lymphatic filariasis (LF) as a public health problem globally by 2020.
Anisa A Omar   +7 more
core   +4 more sources

A large filarial hydrocele in Kenya: a case report

open access: yesFrontiers in Tropical Diseases
Morbidity Management and Disability Prevention (MMDP) remains a key aspect of the Global project for the Elimination of Lymphatic Filariasis (GPELF) a program launched by WHO in the year 2000.
Charles Waihenya   +2 more
doaj   +1 more source

Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India

open access: yesBulletin of the World Health Organization, 2007
OBJECTIVE: To determine the role of vector control in further decreasing the transmission of bancroftian filariasis achieved by mass drug administration and the long-term impact on filariometric indices.
IP Sunish   +5 more
doaj  

Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia. [PDF]

open access: yes, 2010
: BACKGROUND: The World Health Organization (WHO) Global Program to Eliminate Lymphatic Filariasis relies on mass drug administration (MDA) of two drugs annually for 4 to 6 years.
Bhullar, Navneet, Maikere, Jacob
core   +3 more sources

Irreversible Effects of Ivermectin on Adult Parasites in Onchocerciasis Patients in the Onchocerciasis Control Programme in West Africa [PDF]

open access: yes, 2017
Ivermectin is an effective drug for the treatment of human onchocerciasis, a disease caused by the parasitic filarial nematode Onchocerca volvulus.
Alley, E. Soumbey   +7 more
core  

Prevalence of soil transmitted nematodes on Nukufetau, a remote Pacific island in Tuvalu [PDF]

open access: yes, 2006
Background: The population of Nukufetau, a remote coral atoll island in Tuvalu in the Western Pacific, received annual mass drug administration (MDA) of diethylcarbamazine and albendazole under the Pacific Elimination of Lymphatic Filariasis program in ...
Rick Speare   +37 more
core   +2 more sources

Diethylcarbamazine Attenuates the Development of Carrageenan-Induced Lung Injury in Mice

open access: yesMediators of Inflammation, 2014
Diethylcarbamazine (DEC) is an antifilarial drug with potent anti-inflammatory properties as a result of its interference with the metabolism of arachidonic acid.
Edlene Lima Ribeiro   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy